Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases

This publication has 16 references indexed in Scilit:

• Association of serum sialic acid and MMP‐9 with lipids and inflammatory markers
  European Journal of Clinical Investigation, 2000
• Mechanisms modifying atherosclerotic disease — from lipids to vascular biology
  Atherosclerosis, 1999
• Inhibition of proinflammatory cytokine production by pravastatin
  The Lancet, 1999
• Effects of Oxidized Low Density Lipoprotein, Lipid Mediators and Statins on Vascular Cell Interactions
  Clinical Chemistry and Laboratory Medicine (CCLM), 1999
• Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic Plaques
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progression
  The American Journal of Cardiology, 1995
• Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
  Circulation, 1995
• Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.
  Proceedings of the National Academy of Sciences, 1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization.
  Journal of Histochemistry & Cytochemistry, 1994